Critical appraisal of dabigatran in the treatment of deep vein thrombosis and pulmonary embolism

References

• Weill-EngererSMeaumeSLahlouARisk factors for deep vein thrombosis in inpatients aged 65 and older: a case-control multicenter studyJ Am Geriatr Soc20045281299130415271117
   PubMed Web of Science ®Google Scholar
• BramlagePPittrowDKirchWCurrent concepts for the prevention of venous thromboembolismEur J Clin Invest200535Suppl 141115701142
   PubMed Web of Science ®Google Scholar
• GeldhofVVandenbrieleCVerhammePVanasscheTVenous thromboembolism in the elderly: efficacy and safety of non-VKA oral anticoagulantsThromb J2014122125650285
   PubMed Web of Science ®Google Scholar
• ReitsmaPHVersteegHHMiddeldorpSMechanistic view of risk factors for venous thromboembolismArterioscler Thromb Vasc Biol201232356356822345594
   PubMed Web of Science ®Google Scholar
• CohenATAgnelliGAndersonFAVTE Impact Assessment Group in Europe (VITAE). Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortalityThromb Haemost200798475676417938798
   PubMed Web of Science ®Google Scholar
• DeitelzweigSBJohnsonBHLinJSchulmanKLPrevalence of clinical venous thromboembolism in the USA: current trends and future projectionsAm J Hematol201186221722021264912
   PubMed Web of Science ®Google Scholar
• GiannakopoulosBPassamFRahgozarSKrilisSACurrent concepts on the pathogenesis of the antiphospholipid syndromeBlood2007109242243016985176
   PubMed Web of Science ®Google Scholar
• RosendaalFRHelmerhorstFMVandenbrouckeJPFemale hormones and thrombosisArterioscler Thromb Vasc Biol200222220121011834517
   PubMed Web of Science ®Google Scholar
• GouldMKGarciaDAWrenSMAmerican College of Chest PhysiciansPrevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesChest20121412 Supple227Se277S22315263
   PubMed Web of Science ®Google Scholar
• KahnSRLimWDunnASAmerican College of Chest PhysiciansPrevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesChest20121412 Supple195Se226S22315261
   PubMed Web of Science ®Google Scholar
• Falck-YtterYFrancisCWJohansonNAAmerican College of Chest PhysiciansPrevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesChest20121412 Supple278Se325S22315265
   PubMed Web of Science ®Google Scholar
• KearonCNatural history of venous thromboembolismCirculation200310723 Suppl 1I22I3012814982
   PubMed Web of Science ®Google Scholar
• BatesSMJaeschkeRStevensSMAmerican College of Chest PhysiciansDiagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesChest20121412 Supple351Se418S22315267
   PubMed Web of Science ®Google Scholar
• GormanWPDavisKRDonnellyRABC of arterial and venous disease. Swollen lower limb-1: general assessment and deep vein thrombosisBMJ200032072471453145610827054
   PubMed Web of Science ®Google Scholar
• KearonCAklEAComerotaAJAmerican College of Chest PhysiciansAntithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesChest20121412 Supple419Se494S22315268
   PubMed Web of Science ®Google Scholar
• TapsonVFAcute pulmonary embolismN Engl J Med2008358101037105218322285
   PubMed Web of Science ®Google Scholar
• MosICKlokFAKroftLJde RoosAHuismanMVImaging tests in the diagnosis of pulmonary embolismSemin Respir Crit Care Med201233213814322648485
   PubMed Web of Science ®Google Scholar
• GoldhaberSZBounameauxHPulmonary embolism and deep vein thrombosisLancet201237998281835184622494827
   PubMed Web of Science ®Google Scholar
• DobeshPPFanikosJNew oral anticoagulants for the treatment of venous thromboembolism: understanding differences and similaritiesDrugs201474172015203225300410
   PubMed Web of Science ®Google Scholar
• StangierJRathgenKStähleHGansserDRothWThe pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjectsBr J Clin Pharmacol200764329230317506785
   PubMed Web of Science ®Google Scholar
• StangierJRathgenKStähleHMazurDInfluence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate: an open-label, parallel-group, single-centre studyClin Pharmacokinet201049425926820214409
   PubMed Web of Science ®Google Scholar
• Pradaxa^® (dabigatran etexilate mesylate) capsules [package insert]Ridgefield, CTBoehringer Ingelheim Pharmaceuticals Inc.2015
   Google Scholar
• MoYYamFKRecent advances in the development of specific antidotes for target-specific oral anticoagulantsPharmacotherapy201535219820725644580
   PubMed Web of Science ®Google Scholar
• Boehringer IngelheimReversal of dabigatran anticoagulant effect with idarucizumab Available from: https://clinicaltrials.gov/ct2/show/NCT02104947. NLM identifier: NCT02104947Accessed March 23, 2015
   Google Scholar
• Boehringer IngelheimBoehringer Ingelheim submits applications for approval of idarucizumab*, specific reversal agent to dabigatran etexilate (Pradaxa^®), to EMA, FDA and Health Canada [press release]Ingelheim, GermanyBoehringer Ingelheim201533 Available from: https://www.boehringer-ingelheim.com/news/news_releases/press_releases/2015/03_march_2015_dabigatranetexilate.htmlAccessed March 23, 2015
   Google Scholar
• SchulmanSKearonCKakkarAKRE-COVER Study GroupDabigatran versus warfarin in the treatment of acute venous thromboembolismN Engl J Med2009361242342235219966341
   PubMed Web of Science ®Google Scholar
• SchulmanSKakkarAKGoldhaberSZRE-COVER II Trial InvestigatorsTreatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysisCirculation2014129776477224344086
   PubMed Web of Science ®Google Scholar
• OgbonnaKCJefferySMRisk versus benefit of non-vitamin K dependent anticoagulants compared to warfarin for the management of atrial fibrillation in the elderlyDrugs Aging201330751352523591934
   PubMed Web of Science ®Google Scholar
• SchulmanSKearonCKakkarAKRE-MEDY Trial Investigators; RE-SONATE Trial InvestigatorsExtended use of dabigatran, warfarin, or placebo in venous thromboembolismN Engl J Med2013368870971823425163
   PubMed Web of Science ®Google Scholar
• ConnollySJEzekowitzMDYusufSRE-LY Steering Committee and InvestigatorsN Engl J Med2009361121139115119717844
   PubMed Web of Science ®Google Scholar
• LaporteSMismettiPDécoususHRIETE InvestigatorsClinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) RegistryCirculation2008117131711171618347212
   PubMed Web of Science ®Google Scholar
• LymanGHKhoranaAAKudererNMAmerican Society of Clinical Oncology Clinical PracticeVenous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline updateJ Clin Oncol201331172189220423669224
   PubMed Web of Science ®Google Scholar
• Institute for Safe Medication PracticesQuarterWatch. Monitoring FDA MedWatch Reports: Signals for Dabigatran and MetoclopramideHorsham, PAInstitute for Safe Medication Practices2012 Available from: http://www.ismp.org/QuarterWatch/pdfs/2011Q1.pdfAccessed April 20, 2015
   Google Scholar
• FrederickAAJrSpencerFARisk factors for venous thromboembolismCirculation200310723 Suppl I916
   Google Scholar
• FennerKSTroutmanMDKempshallSDrug-drug interactions mediated through P-glycoprotein: clinical relevance and in vitro-in vivo correlation using digoxin as a probe drugClin Pharmacol Ther200985217318118987624
   PubMed Web of Science ®Google Scholar